Author:
Leiva María Carmen,Ortiz Raúl,Contreras-Cáceres Rafael,Perazzoli Gloria,Mayevych Iryna,López-Romero Juan Manuel,Sarabia Francisco,Baeyens Jose Manuel,Melguizo Consolación,Prados Jose
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Gornstein, E. & Schwarz, T. L. The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions. Neuropharmacology 76, 175–183 (2014).
2. Marupudi, N. I. et al. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert. Opin. Drug Saf. 6, 609–621 (2007).
3. Surapaneni, M. S., Das, S. K. & Das, N. G. Designing paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges. ISRN Pharmacol. 623139, 12 (2012).
4. Feng, L. & Mumper, R. J. A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett. 334, 157–175 (2013).
5. Kundranda, M. N. & Niu, J. Albumin-bound paclitaxel in solid tumors: clinical development and future directions. Des. Devel. Ther. 9, 3767–3777 (2015).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献